Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
enzyme
Research
'Programmable molecular scissors' to snip COVID-causing virus
Scientists have developed synthetic enzymes that kill viruses by targeting their genomes and cutting them into pieces.
Helen Floersh
Nov 18, 2022 8:50am
Aeglea's search for efficacy in phase 3 data impresses investors
Apr 12, 2022 7:17am
Liver enzyme might hold the secret to new obesity treatments
Apr 11, 2022 4:42pm
Investors punish Aeglea for missed rare disease secondaries
Dec 6, 2021 9:05am
I-Mab hits the deal table with biopharma majors: report
Sep 29, 2021 8:20am
The link between COVID-19, rattlesnake venom and a killer enzyme
Aug 24, 2021 1:00pm